C. O'Doherty

Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?

T. Lister, R. Gupta, J. Shamash, 2000, Acta oncologica.

Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy

T. Lister, R. Gupta, J. Shamash, 2000, British Journal of Cancer.

Prevalence and characteristics of breakthrough pain in patients with non-malignant terminal disease admitted to a hospice

S. Collins, G. Zeppetella, C. O'Doherty, 2001, Palliative Medicine.

Prevalence and characteristics of breakthrough pain in cancer patients admitted to a hospice.

S. Collins, G. Zeppetella, C. O'Doherty, 2000, Journal of pain and symptom management.

Drugs and syringe drivers: A survey of adult specialist palliative care practice in the United Kingdom and Eire

E. Hall, L. Schofield, C. O'Doherty, 2001, Palliative medicine.

Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study.

R. Perera, Ly-Mee Yu, B. Nicholson, 2023, The Lancet. Oncology.

Large-scale observational prospective cohort study of a multi-cancer early detection (MCED) test in symptomatic patients referred for cancer investigation.

R. Perera, M. Middleton, B. Nicholson, 2023, Journal of Clinical Oncology.

Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma.

J. Shamash, M. Tischkowitz, R. Rudd, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.